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Abstract
Background—Data on the relations of different types of fish meals and long-chain n-3
polyunsaturated fatty acids (n-3 PUFAs) with measures of atherosclerosis are sparse.
Objective—We examined intakes of long-chain n-3 PUFAs and fish in relation to clinical
measures of subclinical atherosclerosis.
Design—A cross-sectional study was conducted in 5,488 multiethnic adults aged 45–84 years
and free of clinical cardiovascular disease. Diet was assessed using self-administered food
frequency questionnaires. Subclinical atherosclerosis was determined by common carotid intima-
media thickness (cCIMT, >80th percentile), internal CIMT (iCIMT, >80th percentile), coronary
artery calcium score (CAC, >0) or ankle-brachial index (ABI, <0.90), respectively.
Results—After adjustment for potential confounders, intakes of long-chain n-3 PUFAs and non-
fried (broiled, steamed, baked or raw) fish were inversely related to subclinical atherosclerosis
determined by cCIMT but not iCIMT, CAC or ABI. The multivariable odds ratio comparing the
highest to the lowest quartile of dietary exposures in relation to subclinical atherosclerosis
determined by cCIMT was 0.69 (95% CI: 0.55, 0.86; p for trend<0.01) for n-3 PUFA intake, 0.80
(95% CI: 0.64, 1.01; p=0.054) for non-fried fish and 0.90 (95% CI: 0.73, 1.10; p=0.33) for fried
fish consumption.
Conclusions—This study indicates that dietary intake of long-chain n-3 PUFAs or non-fried
fish is associated with lower prevalence of subclinical atherosclerosis classified by cCIMT
although significant changes in iCIMT, CAC and ABI were not observed. Our findings also
suggest that the association of fish and atherosclerosis may vary depending on the type of fish
meal consumed and the measures of atherosclerosis.
Keywords
long-chain n-3 polyunsaturated fatty acids; fish; fish oil; biomarker; subclinical atherosclerosis;
multi-ethnicities
INTRODUCTION
Observational studies and randomized trials have indicated that higher intakes of long-chain
n-3 polyunsaturated fatty acids (n-3 PUFAs) including eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) and fish are associated with lower risk of cardiovascular
disease.(1–4) Possible mechanisms underlying this cardioprotective effect include reduction
of serum triglycerides,(5) decreased platelet aggregability,(6) and anti-arrhythmic effects.(6)
While the hypotriglyceridemic effects of supplementation with high dose long-chain n-3
PUFAs are well established,(7) these fatty acids may also increase low density lipoprotein
(LDL) cholesterol(8, 9) and enhance oxidation of LDL cholesterol.(10, 11) Indeed, previous
studies do not reveal a clear picture of the effects of long-chain n-3 PUFAs or fish on
subclinical atherosclerosis. Data from both animal models(12–14) and humans(15–17) are
inconsistent.
He et al. Page 2






















Computed tomography scanning of the coronary arteries for calcium is widely used as a
non-invasive method for assessing early coronary artery disease. The presence of coronary
artery calcium (CAC) is a predictor of increased risk for future coronary events.(18, 19) The
ultrasonographic evaluation of the carotid intimal-medial thickness (CIMT) is also utilized
to assess carotid atherosclerosis.(20, 21) In addition, a low ankle-brachial index (ABI) has
been reported to be associated with an increased risk of death, total cardiovascular disease,
coronary heart disease, congestive heart failure, and symptomatic peripheral arterial disease.
(22–25) Although these measurements are widely employed as markers of subclinical
atherosclerosis in various epidemiologic studies, few studies have used these measurements
simultaneously in a single cohort.
To determine whether the previous inconsistent findings on fish and subclinical
atherosclerosis can be partially explained by the different clinical measures used and how
different types of fish meals related to atherosclerosis, we examined fish consumption and
long-chain n-3 PUFA intake in relation to clinical measures of atherosclerosis including
common CIMT (cCIMT), internal CIMT (iCIMT), CAC and ABI in a cohort of multi-
ethnic, middle-aged and older, men and women.
PARTICIPANTS AND METHODS
Study Population
The Multi-Ethnic Study of Atherosclerosis (MESA) is a population based study of 6814 men
and women aged 45 to 84 years, without clinical cardiovascular disease, recruited from 6
U.S. communities. Participants were enrolled between August 1, 2000, and July 30, 2002.
The self-identified ethnic background of the cohort is 38.5% Caucasians, 27.8% African
Americans, 21.9% Hispanics, and 11.8% Chinese. The primary goal of the MESA Study is
to determine the characteristics associated with subclinical cardiovascular disease and its
progression. Details of sampling and recruitment procedures have been published else
where.(26) Participants completed a set of measurements of subclinical cardiovascular
disease and assessment of standard cardiovascular disease risk factors, sociodemographic
factors, diet, lifestyle, and psychosocial factors. In the present analysis, we excluded those
who had missing data on diet (n=577), ABI (n=70), cCIMT (n=74), iCIMT (n=98), and who
had extreme total energy intake (<600 or >6000 kcal/day, n=285). We also excluded
participants without information on covariates used in the analysis (n=222). After these
exclusions, a total of 5488 participants remained in the analysis.
The MESA protocol was approved by institutional review boards at all participating sites,
and all participants provided informed consent.
Dietary Assessment
Dietary information was assessed using a self-administered food frequency questionnaire
(FFQ) and dietary supplement form. The FFQ was based on a FFQ used in the tri-ethnic
(non-Hispanic Caucasians, African Americans, and Hispanics) Insulin Resistance
Atherosclerosis Study (IRAS) and was modified for the Diabetes Prevention Program to
include foods typically consumed by a Chinese population and to collect supplemental
information.(26, 27) Participants were asked to identify usual frequency of consumption of
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the food items during the past year and the average serving size consumed. Nine frequency
responses were available in the questionnaire, ranging from “never/rare” to “2+ per day”,
and three serving sizes were specified: small, medium, and large. In this study, fish
consumption was defined as fish and other seafood intake. Participants were asked to
indicate how often they consumed 1) fried fish or fish sandwich, fried shrimp, calamari; 2)
shrimp, lobster, crab, oysters, mussels (not fried); 3) tuna, salmon, sardines (including
sashimi or sushi); and 4) other broiled, steamed, baked or raw fish (such as trout, sole,
halibut, poke, grouper). Studies suggested that the preparation method particularly frying
might substantially alter the fatty acid content of a fish meal(28) and the associations with
cardiovascular disease risk might be different.(29) Also, long-chain n-3 PUFA contents in
shell fish are relatively low. Therefore, we divided fish consumption into three groups: fried
fish (including fried shell fish), non-fried fish (broiled, steamed, baked or raw fish) and non-
fried fish + shell fish. Because near 50% participants reported no shell fish consumption, we
were not able to analyze shell fish separately. In the questionnaire, there are also three
questions related to mixed fish dish such as Chinese food with stir-fried shrimp or fish with
vegetables; pasta with seafood; and seafood gumbo. Because we were not able to determine
the exact portion of seafood in the mixed fish dish, we did not include mixed fish dishes in
the main analyses. However, we included mixed fish dishes in the secondary analyses by
assigning a weight 0.4, 0.5 or 0.6 respectively to the mixed fish dish. We converted fish
consumption into servings per day and adjusted for serving size (i.e. small = 0.5 × medium;
medium = standard age- and gender-specific serving size; large = 1.5 × medium).(30)
Nutrients including long-chain n-3 PUFAs were derived from the Minnesota nutrition data
system (NDS-R version 4.02/30).(31) Information on the dose of supplements including fish
oil was acquired. Also, dose of supplements was included in estimation of nutrient intake.
Although the FFQ has not been validated in MESA, the IRAS questionnaire has
demonstrated reasonable validity and reliability in a diverse cohort.(32) Compared to the
average of eight 24-hour recalls, the mean correlation coefficients of nutrient intake were
0.62 for non-Hispanic Caucasians, 0.5 for African Americans, and 0.41 for Hispanics. The
relatively lower observed correlations among Hispanics were largely accounted for by
differences in education across the ethnicities. For reliability, the mean correlation
coefficient for nutrients evaluated was 0.62 and did not differ by ethnic subgroup.
Measures of Subclinical Atherosclerosis
In this study, subclinical atherosclerosis was defined by CAC, cCIMT, iCIMT and ABI,
respectively. CAC was measured using 2 scans obtained on the same occasion in all
participants during the clinical examination using electron beam computed tomography or
multi-detector computed tomography.(33) The presence of CAC (Agatston score > 0) was
considered as a marker of subclinical atherosclerosis.
IMT was measured between lumen-intima and media-adventitia interfaces of near and far
walls of the common carotid artery (the 1 cm segment proximal to the bifurcation) and the
internal carotid artery (including the bifurcation and 1cm distal to the bifurcation) with B-
mode ultrasound (Logiq 700 ultrasound machine; General Electric Medical Systems).(34)
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Subclinical atherosclerosis was defined by the values of cCIMT or iCIMT index of greater
than 80th percentile values.
All participants were evaluated in the supine position after at least 5 minutes of rest. Systolic
blood pressure was measured in arms and in the right and left posterior tibial and dorsalis
pedis artery. The resting ABI was determined for each leg by dividing the systolic blood
pressure at the ankle by the brachial pressure; the lower of the ABI values obtained in each
leg was used in the data analysis.(35) An ABI value less than 0.9 was classified as
subclinical atherosclerosis in this analysis.
Other Covariates Assessment
Demographic and major lifestyle variables were collected through questionnaire; including
age, gender, race/ethnicity, education level, household income, smoking status, medical
conditions, and current medication use. Body weight and height were directly measured
according to standard procedures. Body mass index (BMI) was calculated as the ratio of
weight (kg) to squared height (m). Physical activity was measured using a detailed, semi-
quantitative questionnaire adopted from the Cross-Culture Activity Participation Study.(26)
Total physical activity was computed as the total intentional exercise (all light, moderate,
and vigorous activities [minutes per week]) multiplied by the activities’ individual metabolic
equivalent values.
Statistical analysis
Quartiles of fish consumption and long-chain n-3 PUFA intake were created and used in the
analysis. Age-, sex- and race-adjusted means and standard errors or proportions were
computed for selected variables by quartiles of long-chain n-3 PUFA intake. Logistic
regression analyses were used to examine the associations of fish consumption and long-
chain n-3 PUFA intake with subclinical atherosclerosis, which are classified by cCIMT
(>80th percentile), iCIMT (>80th percentile), CAC (Agatston score >0), or ABI (<0.90). We
considered a number of potential confounders in the multivariable models including age,
race/ethnicity, sex, BMI, physical activity, household income, smoking status, systolic blood
pressure, antihypertensive medication use, and several dietary variables. We first ran a basic
model by including a few demographic variables. Other major lifestyle factors and dietary
variables were included in the analysis as potential confounders based on previous studies
and statistical tests. Covariates were added to the basic regression model in a hierarchical
fashion so that we can assess the impact of adjusting for specific confounders on the
association of each combination of dietary exposure and clinical measures of
atherosclerosis. Also, we adjusted for fried fish when examining non-fried fish and verse
visa. Test for trends across quartiles was evaluated using the median values of each quartile
of fish and long-chain n-3 PUFA intake. In a sensitivity analysis, different cut-off points (10,
50, 100, and 200) were used for CAC to see if the results on fish or long-chain n-3 PUFAs
and CAC were robust. All p values were two-sided with the p value less than 0.05
considered statistically significant. SAS (version 9; SAS Institute, Inc., Cary, North
Carolina) software was used for all analyses.
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Table 1 shows age-, sex- and race- adjusted characteristics of the study population according
to dietary intake of long-chain n-3 PUFA. The median daily intakes of long-chain n-3 PUFA
across quartiles were 40 mg, 80 mg, 120 mg and 220 mg respectively. Compared to
participants in the lowest quartile of long-chain n-3 PUFA intake, those who in the highest
quartile were more likely to have higher education and household income; they exercised
more, and were less likely to be current smokers. Also, participants in the highest quartile of
long-chain n-3 PUFA intake had lower intakes of alcohol, total energy, saturated fat and
trans fat, and higher intake of alpha-linolenic acid.
In multivariable analysis, a significant inverse association was observed between long-chain
n-3 PUFA intake and subclinical atherosclerosis determined by cCIMT. The odds of having
cCIMT greater than 80th percentile was 31% lower (odds ratio [OR], 0.69; 95% confidence
interval [CI], 0.55, 0.86; p for trend = 0.005) for participants in the highest quartile of long-
chain n-3 PUFA intake as compared to those who in the lowest quartile (Table 2). Increasing
non-fried fish consumption was related to decreased odds of having cCIMT greater than 80th
percentile (OR, 0.80; 95% CI, 0.64, 1.01; p for trend = 0.054) but this inverse association
was attenuated by including shell fish (OR, 0.84; 95% CI, 0.67, 1.04; p for trend = 0.15).
Fried fish was not related to cCIMT. In addition, no inverse associations were observed,
however, between long-chain n-3 PUFA intake, non-fried fish, non-fried fish + shell fish,
and fried fish consumption with subclinical atherosclerosis classified by iCIMT, CAC or
ABI (Table 2).
After adjustment for potential confounders, long-chain n-3 PUFA intake and fish
consumption were significantly inversely related to blood triglyceride levels. Also, intakes
of long-chain n-3 PUFAs and non-fried fish were positively associated with blood high-
density lipoprotein (HDL) cholesterol levels. The ratio of total and HDL cholesterol has
been suggested as a powerful predictor of coronary heart disease.(36) In this study, dietary
long-chain n-3 PUFA intake but not fish consumption was significantly inversely related to
the ratio of total and HDL cholesterol (Table 3).
By stratifying data, we found that the inverse associations between non-fried fish
consumption or long-chain n-3 PUFA intake and cCIMT were not appreciably modified by
gender. The p values for interaction tests of gender with long-chain n-3 PUFAs and non-
fried fish were 0.95 and 0.57 respectively. In addition, the observed inverse associations
remained in Caucasians but not other ethnicities (data not shown).
In sensitivity analyses (data not shown), we used different cut-off points (10, 50, 100, and
200) for CAC, the results were not materially altered. In addition, approximately 4%
participants used fish oil supplements. The results remained when we excluded the
supplement users in the analyses. In this study, we were not able to analyze shell fish
separately because near half of the participants reported no shell fish consumption.
Nevertheless, no association with any of the clinical markers was observed by
dichotomizing shell fish consumption. Moreover, we included mixed fish dishes in the
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analysis by assigning a weight 0.4, 0.5 or 0.6 respectively to mixed fish dish. The observed
inverse associations were slightly attenuated.
DISCUSSION
In this cross-sectional study, we found that dietary intake of long-chain n-3 PUFAs and non-
fried fish consumption were associated with a lower prevalence odds ratio of subclinical
atherosclerosis classified by cCIMT but not iCIMT, CAC or ABI. The inverse associations
were consistent in men and in women.
In spite of potential benefits of dietary long-chain n-3 PUFAs in the reduction of coronary
heart disease mortality,(3) it is not clear whether long-chain n-3 PUFAs have a direct effect
on the pathogenesis of atherosclerosis. A randomized controlled trial among 59 patients with
angiographically documented coronary heart disease reported that fish oil treatment (6
grams EPA and DHA daily) for 2 years had no major favorable effect on the diameter of
atherosclerotic coronary arteries.(15) Another randomized, double-blind, placebo-controlled
trial in 223 patients with angiographically proven coronary artery disease found that fish oil
intake, approximately 1.65 grams EPA and DHA daily for 2 years, modestly mitigated the
course of human coronary atherosclerosis,(16) but had no effect on progression of carotid
atherosclerosis.(37) Change in atherosclerosis extent in carotid arteries and in coronary
arteries in these patients during the same period was not correlated.(37) The association of
fish or long-chain n-3 PUFAs with atherosclerosis was also examined in observational
studies. A cross-sectional study conducted in 470 Japanese found that serum long-chain n-3
PUFA level was inversely related to probability of common carotid plaques.(38) Also, a
prospective cohort study of postmenopausal women with coronary artery disease (n=229)
found that fish consumption was associated with significantly less progression of coronary
atherosclerosis.(17)
The effects of long-chain n-3 PUFAs on atherosclerosis may be mediated through their roles
in lipoprotein metabolism. In this study, we found that fish and long-chain n-3 PUFA
intakes were associated with lower triglyceride levels. Long-chain n-3 PUFAs and non-fried
fish were positively related to HDL. Long-chain n-3 PUFAs were also inversely associated
with the ratio of total and HDL cholesterol. No statistically significant associations were
found for LDL and total cholesterol. A recent meta-analysis of 21 randomized controlled
trials summarized the effects of fish oil supplementation on lipid values.(39) The meta-
analysis suggests that fish oil consumption significantly decreases serum triglycerides and
modestly improves HDL. However, fish oil intake increases the level of LDL cholesterol
and has no effect on total cholesterol. It is uncertain how these combined effects of long-
chain n-3 PUFAs on lipid values affect the development or progression of atherosclerosis. In
addition, long-chain n-3 PUFAs may have an anti-platelet aggregation effect,(40, 41) and
have a modest hypotensive effect.(42) Moreover, studies indicate that long-chain n-3 PUFAs
have anti-inflammatory effects and may improve endothelial function.(43, 44) The
associations of long-chain n-3 PUFAs with atherosclerosis might reflect the integrative
effects of long-chain n-3 PUFAs with lipids, thrombosis, inflammation, and endothelial
function.
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A major strength of our study is that we have multiple clinical measures of subclinical
atherosclerosis. However, in this study, we only observed an inverse association between
long-chain n-3 PUFAs and cCIMT. Although all of these measurements are recognized as
markers of subclinical atherosclerosis, they may be different surrogates of the
atherosclerotic process. For example, ABI is generally thought of as the best clinical marker
of diffuse atherosclerosis. CAC may reflect atherosclerosis in coronary arteries. cCIMT and
iCIMT are considered as markers of carotid atherosclerosis. We found that dietary long-
chain n-3 PUFAs were associated with cCIMT but not iCIMT. One possible explanation is
that iCIMT mainly reflects hypertension status but not carotid atherosclerosis per se. Of
note, intakes of long-chain n-3 PUFAs and fish were relatively low in this cohort. The
observed null associations in this study might be partially explained by the low long-chain
n-3 PUFA intake or fish consumption. Nevertheless, significant risk reduction of ischemic
stroke with similar amount of long-chain n-3 PUFA intake was reported.(45) In addition, we
examined the associations among multiple ethnic groups. Although qualitatively similar
associations were observed across ethnicities, the statistically significant inverse
associations between long-chain n-3 PUFAs and cCIMT only remained in Caucasians.
Notably, Caucasian is the largest ethnic group in MESA. The relatively small numbers of
participant identified having cCIMT greater than 80th percentile in other ethnicities
especially in Chinese and Hispanics might limit our ability to observe any possible
significant association. Another strength of this study is that we examined separately fried
fish, non-fried fish and non-fried fish + shell fish consumption in relation to measures of
atherosclerosis. Shell fish contains relatively low levels of long-chain n-3 PUFAs. In this
study, the observed inverse association between non-fried fish and cCIMT was attenuated by
including shell fish. Although it was modestly inversely related to blood triglyceride levels,
we found no beneficial effects of fried fish consumption on atherosclerosis. Our findings are
biologically plausible since frying may affect a fish meal’s fatty acid composition(28)
including reducing long-chain n-3 PUFA content and producing trans-unsaturated fatty
acids. These changes in fatty acid profile of cooked fish meals may somewhat attenuate or
cancel the potential benefit of fish consumption.
Our study has some limitations. First, given the cross-sectional analysis, the possibility of
reverse causation can not be completely excluded. Also, we could not account for the effects
of changes in diet on atherosclerosis. For example, some participants who were at high risk
of cardiovascular disease might have changed their diet (e.g., increased fish consumption or
took fish oil supplement) based on advice from physicians or information via media sources.
This diet change could dilute any inverse association of long-chain n-3 PUFAs or fish and
subclinical atherosclerosis. Second, dietary intake was self-reported in this study, the
inevitable measurement errors in estimating fish consumption as well as long-chain n-3
PUFA intake could bias our results. Third, although we adjusted for a number of potential
confounders in the analysis, residual confounding and possible confounding from
unmeasured dietary and non-dietary factors could not be ruled out. For example, information
on mercury and other contaminants in fish was not available. Study suggests that mercury
may increase risk of myocardial infarction.(46) Thus, mercury in fish might confound our
findings. Fourth, near 20% participants were excluded in the analyses mainly because of the
missing data. Although the characteristics of these two groups were not significantly
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different, the results might be affected by the exclusions. Finally, the relatively small
numbers of participant with ABI < 0.90 might limit our capability to examine the
associations using the ABI as the measure of subclinical atherosclerosis.
In summary, our study indicates that dietary intakes of long-chain n-3 PUFAs and non-fried
fish are inversely associated with subclinical atherosclerosis determined by cCIMT but not
iCIMT, CAC or ABI. Our findings also suggest that results of clinical and epidemiologic
research may differ according to the measures employed to assess atherosclerosis and the
type of fish meal consumed.
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